H2N2V1, PubMed, Checkpoint, bibRecord, 000452

Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.

Identifieur interne : 000452 ( PubMed/Checkpoint ); précédent : 000451; suivant : 000453

Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.

Auteurs : R. Pyh L

Source :

The Journal of hygiene [ 0022-1724 ] ; 1985.

RBID : pubmed:4067298

Descripteurs français

KwdFr :
- Anticorps antiviraux (analyse), Finlande, Flambées de maladies (immunologie), Grippe humaine (immunologie), Humains, Hémagglutinines virales (immunologie), Immunité, Sialidase (immunologie), Sous-type H1N1 du virus de la grippe A, Sous-type H2N2 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A, Spécificité des anticorps, Virus de la grippe A (immunologie).
MESH :
- analyse : Anticorps antiviraux.
- immunologie : Flambées de maladies, Grippe humaine, Hémagglutinines virales, Sialidase, Virus de la grippe A.
- Finlande, Humains, Immunité, Sous-type H1N1 du virus de la grippe A, Sous-type H2N2 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A, Spécificité des anticorps.
Wicri :
- geographic : Finlande.

English descriptors

KwdEn :
- Antibodies, Viral (analysis), Antibody Specificity, Disease Outbreaks (immunology), Finland, Hemagglutinins, Viral (immunology), Humans, Immunity, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H2N2 Subtype, Influenza A Virus, H3N2 Subtype, Influenza A virus (immunology), Influenza, Human (immunology), Neuraminidase (immunology).
MESH :
- chemical , analysis : Antibodies, Viral.
- chemical , immunology : Hemagglutinins, Viral, Neuraminidase.
- geographic : Finland.
- immunology : Disease Outbreaks, Influenza A virus, Influenza, Human.
- Antibody Specificity, Humans, Immunity, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H2N2 Subtype, Influenza A Virus, H3N2 Subtype.

Abstract

The incidence of haemagglutination inhibition (HI) antibody (titre greater than or equal to 12) to influenza A/Singapore/1/57(H2N2) in sera collected from a Finnish population in the summer of 1981 was 58%. Subjects born after 1968 were essentially seronegative, and a comparable low HI antibody status was also recorded among the elderly, the lowest being in people born during the period 1901-10. A small increase in antibody titre to the H2N2 virus was observed in the different age groups after infections with the H3N2, but not the H1N1, subtype influenza A viruses. The heterotypic response, which could be due to HI or NA antibodies, was restricted almost exclusively to subjects already exhibiting this antibody in acute phase sera. Moreover, the anamnestic boosting was not as strong as that described in earlier studies from samples collected at the beginning of the present era of H3N2 viruses. At population level, the HI antibody status to H2N2 was about the same at the beginning and end of the follow-up period which covered eight epidemic seasons. The results are discussed with respect to the doctrine of 'original antigenic sin' and to the threat of re-emergence of the H2N2 viruses.

DOI: 10.1017/s0022172400062860
PubMed: 4067298

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000502
to stream PubMed, to step Curation: 000502

Links to Exploration step

pubmed:4067298

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.</title>
<author><name sortKey="Pyh L, R" sort="Pyh L, R" uniqKey="Pyh L R" first="R" last="Pyh L">R. Pyh L</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1985">1985</date>
<idno type="RBID">pubmed:4067298</idno>
<idno type="pmid">4067298</idno>
<idno type="doi">10.1017/s0022172400062860</idno>
<idno type="wicri:Area/PubMed/Corpus">000502</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000502</idno>
<idno type="wicri:Area/PubMed/Curation">000502</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000502</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000452</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000452</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.</title>
<author><name sortKey="Pyh L, R" sort="Pyh L, R" uniqKey="Pyh L R" first="R" last="Pyh L">R. Pyh L</name>
</author>
</analytic>
<series><title level="j">The Journal of hygiene</title>
<idno type="ISSN">0022-1724</idno>
<imprint><date when="1985" type="published">1985</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (analysis)</term>
<term>Antibody Specificity</term>
<term>Disease Outbreaks (immunology)</term>
<term>Finland</term>
<term>Hemagglutinins, Viral (immunology)</term>
<term>Humans</term>
<term>Immunity</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza, Human (immunology)</term>
<term>Neuraminidase (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (analyse)</term>
<term>Finlande</term>
<term>Flambées de maladies (immunologie)</term>
<term>Grippe humaine (immunologie)</term>
<term>Humains</term>
<term>Hémagglutinines virales (immunologie)</term>
<term>Immunité</term>
<term>Sialidase (immunologie)</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H2N2 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
<term>Spécificité des anticorps</term>
<term>Virus de la grippe A (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Hemagglutinins, Viral</term>
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Finland</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Flambées de maladies</term>
<term>Grippe humaine</term>
<term>Hémagglutinines virales</term>
<term>Sialidase</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Disease Outbreaks</term>
<term>Influenza A virus</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Antibody Specificity</term>
<term>Humans</term>
<term>Immunity</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Finlande</term>
<term>Humains</term>
<term>Immunité</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H2N2 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
<term>Spécificité des anticorps</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Finlande</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The incidence of haemagglutination inhibition (HI) antibody (titre greater than or equal to 12) to influenza A/Singapore/1/57(H2N2) in sera collected from a Finnish population in the summer of 1981 was 58%. Subjects born after 1968 were essentially seronegative, and a comparable low HI antibody status was also recorded among the elderly, the lowest being in people born during the period 1901-10. A small increase in antibody titre to the H2N2 virus was observed in the different age groups after infections with the H3N2, but not the H1N1, subtype influenza A viruses. The heterotypic response, which could be due to HI or NA antibodies, was restricted almost exclusively to subjects already exhibiting this antibody in acute phase sera. Moreover, the anamnestic boosting was not as strong as that described in earlier studies from samples collected at the beginning of the present era of H3N2 viruses. At population level, the HI antibody status to H2N2 was about the same at the beginning and end of the follow-up period which covered eight epidemic seasons. The results are discussed with respect to the doctrine of 'original antigenic sin' and to the threat of re-emergence of the H2N2 viruses.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">4067298</PMID>
<DateCompleted><Year>1986</Year>
<Month>01</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>05</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1724</ISSN>
<JournalIssue CitedMedium="Print"><Volume>95</Volume>
<Issue>2</Issue>
<PubDate><Year>1985</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of hygiene</Title>
<ISOAbbreviation>J Hyg (Lond)</ISOAbbreviation>
</Journal>
<ArticleTitle>Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.</ArticleTitle>
<Pagination><MedlinePgn>437-45</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The incidence of haemagglutination inhibition (HI) antibody (titre greater than or equal to 12) to influenza A/Singapore/1/57(H2N2) in sera collected from a Finnish population in the summer of 1981 was 58%. Subjects born after 1968 were essentially seronegative, and a comparable low HI antibody status was also recorded among the elderly, the lowest being in people born during the period 1901-10. A small increase in antibody titre to the H2N2 virus was observed in the different age groups after infections with the H3N2, but not the H1N1, subtype influenza A viruses. The heterotypic response, which could be due to HI or NA antibodies, was restricted almost exclusively to subjects already exhibiting this antibody in acute phase sera. Moreover, the anamnestic boosting was not as strong as that described in earlier studies from samples collected at the beginning of the present era of H3N2 viruses. At population level, the HI antibody status to H2N2 was about the same at the beginning and end of the follow-up period which covered eight epidemic seasons. The results are discussed with respect to the doctrine of 'original antigenic sin' and to the threat of re-emergence of the H2N2 viruses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pyhälä</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Hyg (Lond)</MedlineTA>
<NlmUniqueID>0375374</NlmUniqueID>
<ISSNLinking>0022-1724</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006389">Hemagglutinins, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.2.1.18</RegistryNumber>
<NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000918" MajorTopicYN="N">Antibody Specificity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006389" MajorTopicYN="N">Hemagglutinins, Viral</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053121" MajorTopicYN="Y">Influenza A Virus, H2N2 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053122" MajorTopicYN="Y">Influenza A Virus, H3N2 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1985</Year>
<Month>10</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1985</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1985</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">4067298</ArticleId>
<ArticleId IdType="pmc">PMC2129551</ArticleId>
<ArticleId IdType="doi">10.1017/s0022172400062860</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Bull World Health Organ. 1969;41(3):475-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5309458</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am Rev Respir Dis. 1981 Jun;123(6):633-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7271059</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1972 Jul;126(1):61-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4114028</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 1972 Aug;16(2):127-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5072364</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 1973 Jan;97(1):44-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4684066</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 1972;59:75-105</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4570690</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Epidemiol. 1975 Jun;4(2):127-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1165150</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Postgrad Med J. 1979 Feb;55(640):98-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">461278</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hyg (Lond). 1981 Feb;86(1):27-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7193227</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 1982 May;46(1):183-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6281175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hyg (Lond). 1982 Aug;89(1):89-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7097005</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 1982 Aug;116(2):228-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7114034</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Biol. 1982 Dec;60(6):328-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7162226</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hyg (Lond). 1983 Jun;90(3):397-402</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6863911</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull World Health Organ. 1984;62(1):75-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6609021</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hyg (Lond). 1984 Oct;93(2):301-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6389697</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trans Assoc Am Physicians. 1953;66:231-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">13136267</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 1958 Apr 19;1(7025):810-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">13526279</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull World Health Organ. 1969;41(3):507-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5309465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Pyh L, R" sort="Pyh L, R" uniqKey="Pyh L R" first="R" last="Pyh L">R. Pyh L</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000452 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000452 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:4067298
   |texte=   Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:4067298" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021

	Serveur d'exploration H2N2
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration H2N2

Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.

Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki